Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 390.35
+22.65 (6.16%)
At close: Jul 29, 2025
Gujarat Themis Biosyn Company Description
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India.
The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis; Rifamycin-O; and Lovastatin.
The company was incorporated in 1981 and is based in Mumbai, India.
Gujarat Themis Biosyn Limited
| Country | India |
| Founded | 1981 |
| Industry | Medicinal Chemicals and Botanical Products |
| Employees | 159 |
| CEO | Tapas Guhathakurata |
Contact Details
Address: Themis House Mumbai, Gujarat 400104 India | |
| Phone | 91 22 6760 7080 |
| Website | gtbl.in |
Stock Details
| Ticker Symbol | 506879 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Tapas Guhathakurata | Chief Executive Officer |
| Bhavik Shah | Chief Financial Officer |